New Heaven Chemicals and Industries Peer Comparison
BSE: 524484
₹8.00
₹0.00 (0.00%)As on 12-Jan-2017IST
Market cap
₹4 Cr
Revenue (TTM)
₹-- Cr
P/E Ratio
--
P/B Ratio
-0.7
Div. Yield
0 %
Edit
| New Heaven Chemicals and Industries | Wockhardt | Rubicon Research | Piramal Pharma | Acutaas Chemicals | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
4 | 35,442 | 30,431 | 28,125 | 27,651 |
Revenue (₹ Cr) |
-- | 3,564 | 1,936 | 9,205 | 1,462 |
Net Profit (₹ Cr) |
-0.15 | 414.00 | 288.22 | -371.81 | 387.35 |
Net Margin (%) |
-- | 11.23 | 14.79 | -3.93 | 26.01 |
RoE (%) |
-- | 8.38 | 29.77 | -3.85 | 25.18 |
Price to Earnings |
-- | 86.66 | 105.58 | -- | 71.59 |
Price-To-Book |
-0.73 | 7.04 | 22.67 | 3.51 | 16.03 |
Income Statement (₹ Cr)
| New Heaven Chemicals and Industries | Wockhardt | Rubicon Research | Piramal Pharma | Acutaas Chemicals | |
|---|---|---|---|---|---|
|
Operating Revenue
|
-- | 4,014.61 | 48.87 | -- | 160.26 |
|
Total Income
|
0.00 | 4,128.86 | 49.63 | -- | 160.47 |
|
Total Expenditure
|
0.08 | 4,001.81 | 40.20 | -- | 137.13 |
|
EBITDA
|
-0.08 | 12.80 | 8.67 | -- | 23.13 |
|
Depreciation
|
0.02 | 148.93 | 5.11 | -- | 1.37 |
|
EBIT
|
-0.10 | -136.13 | 3.55 | -- | 21.76 |
|
Interest
|
0.00 | 225.27 | 2.85 | -- | 3.30 |
|
Other Income
|
-- | 114.25 | 0.76 | -- | 0.21 |
|
Exceptional Items
|
-- | -- | -- | -- | -- |
|
Profit before Tax
|
-0.10 | -247.15 | 1.46 | -- | 18.68 |
|
Provision for Tax
|
-- | -21.11 | 0.25 | -- | 6.63 |
|
Profit after Tax
|
-0.10 | -226.04 | 1.21 | -- | 12.05 |
Liabilities (₹ Cr)
| New Heaven Chemicals and Industries | Wockhardt | Rubicon Research | Piramal Pharma | Acutaas Chemicals | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
-5.69 | 3,336.71 | 181.42 | -- | 38.99 |
|
Minority Interest
|
-- | 381.94 | -- | -- | -- |
|
Non-Current Liabilities
|
8.89 | 3,151.38 | 15.66 | -- | 15.09 |
|
Current Liabilities
|
0.05 | 1,978.81 | 25.64 | -- | 54.82 |
|
Total Liabilities
|
3.25 | 8,981.96 | 222.72 | -- | 108.94 |
Assets (₹ Cr)
| New Heaven Chemicals and Industries | Wockhardt | Rubicon Research | Piramal Pharma | Acutaas Chemicals | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
3.22 | 4,313.57 | 61.19 | -- | 42.30 |
|
Current Assets
|
0.03 | 4,535.27 | 161.53 | -- | 66.48 |
|
Total Assets
|
3.25 | 8,981.96 | 222.72 | -- | 108.94 |
|
Total Debt*
|
8.89 | 4,159.75 | 27.21 | -- | 26.52 |
|
Net Current Assets
|
-0.01 | 2,556.46 | 135.89 | -- | 11.66 |
|
Contingent Liabilities
|
1.28 | 639.49 | -- | -- | -- |
Cashflow (₹ Cr)
| New Heaven Chemicals and Industries | Wockhardt | Rubicon Research | Piramal Pharma | Acutaas Chemicals | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-0.08 | -269.47 | -4.25 | -- | 28.54 |
|
Cash Flow from Investing Activities
|
-- | -686.64 | -121.87 | -- | -18.61 |
|
Cash from Financing Activities
|
0.08 | 1,254.49 | 127.35 | -- | -7.11 |
|
Net Cash Inflow / Outflow
|
0.00 | 298.38 | 1.23 | -- | 2.82 |
Ratios
Profitability Ratios
| New Heaven Chemicals and Industries | Wockhardt | Rubicon Research | Piramal Pharma | Acutaas Chemicals | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-3.21 | -0.31 | 3.02 | -- | 35.91 |
|
ROE (%)
|
0.00 | -6.42 | 1.15 | -- | 36.44 |
|
ROA (%)
|
-3.18 | -2.69 | 0.77 | -- | 12.04 |
|
EBIT Margin (%)
|
-- | 3.16 | 19.29 | -- | 14.57 |
|
Net Margin (%)
|
-- | -5.47 | 2.43 | -- | 7.51 |
|
Cash Profit Margin (%)
|
-- | -1.92 | 12.93 | -- | 8.37 |
Growth Ratios
| New Heaven Chemicals and Industries | Wockhardt | Rubicon Research | Piramal Pharma | Acutaas Chemicals | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-- | -9.85 | 24.77 | -- | 4.27 |
|
EBIT Growth (%)
|
25.64 | -77.33 | -8.67 | -- | 10.86 |
|
Net Profit Growth (%)
|
26.21 | -189.84 | 31.97 | -- | -4.80 |
|
EPS Growth (%)
|
26.20 | -178.04 | -42.54 | -- | -4.80 |
|
Book Value Growth (%)
|
-1.86 | -11.93 | 516.88 | -- | 42.61 |
Valuation Ratios
| New Heaven Chemicals and Industries | Wockhardt | Rubicon Research | Piramal Pharma | Acutaas Chemicals | |
|---|---|---|---|---|---|
|
Price / Earnings
|
0.00 | 0.00 | 0.00 | -- | 0.00 |
|
Price / Book Value
|
0.00 | 2.41 | 0.00 | -- | 0.00 |
|
Dividend Yield (%)
|
0.00 | 1.39 | -- | -- | -- |
|
EV/EBITDA
|
-174.31 | 82.76 | 3.19 | -- | 1.05 |
|
Market Cap (₹ Cr)
|
-- | 7,958.88 | 0.00 | -- | 0.00 |
Solvency Ratios
| New Heaven Chemicals and Industries | Wockhardt | Rubicon Research | Piramal Pharma | Acutaas Chemicals | |
|---|---|---|---|---|---|
|
Debt to Equity
|
-1.56 | 1.26 | 0.15 | -- | 0.68 |
|
Short term debt to equity ratio
|
-- | 0.20 | 0.06 | -- | 0.23 |
|
Current Ratio
|
0.72 | 2.29 | 6.30 | -- | 1.21 |
|
Quick Ratio
|
0.72 | 1.73 | 6.01 | -- | 0.85 |
|
Interest Coverage
|
-269.90 | -0.10 | 1.51 | -- | 6.67 |
Operating Efficiency Ratios
| New Heaven Chemicals and Industries | Wockhardt | Rubicon Research | Piramal Pharma | Acutaas Chemicals | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
-- | 25.77 | 49.81 | -- | 22.77 |
|
Asset Turnover
|
0.00 | 0.48 | 0.31 | -- | 1.60 |
|
Receivable days
|
-- | 97.55 | 161.61 | -- | 82.89 |
|
Inventory Days
|
-- | 100.47 | 34.91 | -- | 44.82 |
|
Payable days
|
-- | 128.63 | 167.81 | -- | 128.43 |
|
Cash Conversion Cycle
|
-- | 69.38 | 28.72 | -- | -0.72 |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
